Does Indiana Medicaid cover Wegovy and Zepbound in 2026?
No, not for obesity alone. As of Oct 23, 2026, Indiana Medicaid does not cover Wegovy or Zepbound when used only for weight loss.
Not covered for obesity alone Checked Oct 23, 2026 Criteria in effect Jul 1, 2026
Coverage of GLP-1 drugs for obesity alone under Indiana’s fee-for-service Medicaid drug rules, as the state publishes them. The plan decides each request.
Indiana’s rule
In plain words
Not covered for obesity alone
Not covered exclusively for weight loss. The governor announced on Jul 30, 2026 that Indiana will join the federal BALANCE model; no implementation bulletin yet.
Federal BALANCE model: announced Jul 30, 2026, not implemented. The IHCP criteria (07.01.2026) and bulletin BT2026175 (Oct 22, 2026) still show no obesity coverage.
Source
State Medicaid pharmacy vendor (OptumRx): Indiana Medicaid GLP-1 criteria (OptumRx for IHCP), 07.01.2026. Checked Oct 23, 2026.
Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization. Social Security Act §1927(d)(1)(A) and (d)(2)(A), 42 U.S.C. 1396r-8(d) (opens in new tab).
What changed
- Jul 30, 2026: Indiana announced it will join the federal BALANCE model for GLP-1 obesity coverage; no implementation bulletin yet. State of Indiana release, Jul 30, 2026 (opens in new tab)
Next steps
Where to go from here
Neighbouring states
Questions this page answers
Does Indiana Medicaid cover Wegovy and Zepbound for weight loss?
No, not for obesity alone. As of Oct 23, 2026, Indiana Medicaid does not cover Wegovy or Zepbound when used only for weight loss. Not covered exclusively for weight loss. The governor announced on Jul 30, 2026 that Indiana will join the federal BALANCE model; no implementation bulletin yet.
Has Indiana’s rule changed recently?
Jul 30, 2026: Indiana announced it will join the federal BALANCE model for GLP-1 obesity coverage; no implementation bulletin yet.
Where does this information come from?
From Indiana Medicaid’s pharmacy vendor (OptumRx): Indiana Medicaid GLP-1 criteria (OptumRx for IHCP), 07.01.2026, read on Oct 23, 2026. Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization.
Kymata Health reads each state’s own Medicaid documents. See every state on the map.